Quantum-Si incorporated (QSI)
NASDAQ: QSI · Real-Time Price · USD
1.920
-0.030 (-1.54%)
At close: Feb 18, 2025, 4:00 PM
1.930
+0.010 (0.52%)
After-hours: Feb 18, 2025, 7:55 PM EST

Company Description

Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS).

The company’s platform is comprised of the Platinum NGPS instrument; the Platinum Analysis Software service; Proteus, transforming proteomic research; and reagent kits and semiconductor chips for use with its instruments.

It is used in protein identification, protein variants, antibody characterization, biomarker identification, and post translational modification analysis applications.

The company has a collaboration with SkyWaterTechnology for the development of consumable for Proteus, that will enable simultaneous protein sequencing.

Quantum-Si incorporated was founded in 2013 is headquartered in Branford, Connecticut.

Quantum-Si incorporated
Quantum-Si incorporated logo
Country United States
Founded 2013
Industry Medical Devices
Sector Healthcare
Employees 159
CEO Jeffrey Hawkins

Contact Details

Address:
29 Business Park Drive
Branford, Connecticut 06405
United States
Phone 866 688 7374
Website quantum-si.com

Stock Details

Ticker Symbol QSI
Exchange NASDAQ
Stock Type Common Stock
Share Class Class A Shares
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001816431
CUSIP Number 74765K105
ISIN Number US74765K1051
Employer ID 85-1388175
SIC Code 3829

Key Executives

Name Position
Jeffrey Alan Hawkins President, Chief Executive Officer and Director
Dr. Jonathan M. Rothberg Ph.D. Founder and Executive Director
Jeffry R. Keyes CPA Chief Financial Officer and Treasurer
Todd Rearick Chief Technology Officer
Dr. Christian Lapointe J.D., Ph.D. General Counsel and Corporate Secretary
Katherine Atkinson Senior Vice President of Demand Generation and Corporate Brand
Johan Denecke Senior Vice President of Operations
John S. Vieceli Chief Product Officer
Todd C. Bennett Chief Commercial Officer

Latest SEC Filings

Date Type Title
Feb 14, 2025 SCHEDULE 13G/A Filing
Feb 13, 2025 SCHEDULE 13G/A Filing
Feb 4, 2025 SCHEDULE 13G/A Filing
Jan 10, 2025 SCHEDULE 13G/A Filing
Jan 6, 2025 8-K Current Report
Jan 6, 2025 424B5 Filing
Dec 31, 2024 SCHEDULE 13D/A Filing
Dec 27, 2024 144 Filing
Dec 11, 2024 8-K Current Report
Dec 11, 2024 424B5 Filing